CleanSlate UV
800 Steeles Ave. W, #B10182, Thornhill, ON, L4J 7L2, Canada
Overview
CleanSlate UV develops UV-based sanitizing machines designed to disinfect smartphones, tablets, barcode scanners, wireless payment terminals and other portable items. Its machines disinfect 3–4 items at a time in about 20 seconds, use a chemical-free process safe for sensitive touchscreens, and are reported to kill at least 99.979% of SARS-CoV-2. The company targets deployment in hospitals, businesses and other high-traffic environments to place clean devices into clean hands. CleanSlate UV is using government support to move from development toward testing and production of its machines. CEO and cofounder Taylor Mann framed the product as a safe, effective tool to help contain COVID-19 in healthcare and commercial settings. Financially, the company received a $300,000 grant from the Government of Canada’s NRC-IRAP to support R&D and production testing. CleanSlate UV provides chemical-free sanitizing units that use ultraviolet light to kill bacteria and viruses on cell phones and other devices in roughly 20 seconds, disinfecting multiple phones per cycle with no user training required. The product is targeted at doctors, nurses and visitors in healthcare settings and has been deployed in hospitals and food processing facilities in Canada, the United States, and New Zealand. The company is commercializing a software suite that uses automatic RFID scanning to create compliance reports and let managers see when facility-owned devices were last sanitized. The COVID-19 pandemic has driven increased demand across its core healthcare market and broadened interest from food processing, biotechnology, hospitality, and corporate environments. Founded in June 2014 out of Queen’s University, CleanSlate UV previously received a US$500,000 award and an additional US$300,000 from 43North in 2015. The company recently closed an C$8.4M (US$6M) Series A to support geographic and industry expansion and to commercialize its software, and it expects an additional US$1M from angel investors that would bring the round to C$9.8M (US$7M).
- Total raised
- $7M
- Funding rounds
- 2
- Latest round
- Grant
- Latest activity
- Jul 2020
Industries
- Biotechnology
- Electronics
- Medical Device
- mHealth
Recent funding
Grant
Jul 2020
$0M
Equity
Apr 2020
$7M